Entourage Health Corp (FRA:4WE0)

€ 0.0035 0 (0%) Market Cap: 2.06 Mil Enterprise Value: 120.96 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2024 Entourage Health Corp Earnings Call Transcript
Nov 29, 2024

€0.0005

Earnings
Q2 2024 Entourage Health Corp Earnings Call Transcript
Aug 27, 2024

€0.0035 (-12.50%)

Earnings
Q1 2024 Entourage Health Corp Earnings Call Transcript
May 28, 2024

€0.001 (-75.00%)

Earnings
Q3 2023 Entourage Health Corp Earnings Call Transcript
Nov 28, 2023

€0.006 (+50.00%)

Earnings
Q2 2023 Entourage Health Corp Earnings Call Transcript
Aug 30, 2023

€0.007 (+75.00%)

Earnings
Entourage Health Corp Annual Shareholders Meeting Transcript
Jun 14, 2023
Q1 2023 Entourage Health Corp Earnings Call Transcript
May 30, 2023

€0.0105 (+5.00%)

Earnings
Q3 2022 Entourage Health Corp Earnings Call Transcript
Nov 15, 2022

€0.0195

Earnings
Q2 2022 Entourage Health Corp Earnings Call Transcript
Aug 30, 2022

€0.0355 (-1.39%)

Earnings
Entourage Health Corp Annual Shareholders Meeting Transcript
Jun 10, 2022
Q1 2022 Entourage Health Corp Earnings Call Transcript
May 31, 2022

Earnings
Q3 2021 Entourage Health Corp Earnings Call Transcript
Nov 16, 2021

€0.0778 (+0.91%)

Earnings
Q2 2021 Entourage Health Corp Earnings Call Transcript
Aug 10, 2021

€0.1527 (+0.13%)

Earnings
WeedMD Inc Annual Shareholders Meeting Transcript
Jun 30, 2021
Q4 2020 WeedMD Inc Earnings Call Transcript
May 31, 2021

€0.195 (-0.10%)

Earnings
Q3 2020 WeedMD Inc Earnings Call Transcript
Dec 01, 2020

€0.2012 (-8.88%)

Earnings
Q2 2020 WeedMD Inc Earnings Call Transcript
Oct 01, 2020

€0.1797 (-0.17%)

Earnings

Q1 2023 Entourage Health Corp Earnings Call Transcript

May 30, 2023 / 02:00PM GMT

Release Date Price: €0.0105 (+5.00%)

Transcript

Operator

Good morning, everyone, and welcome to the Entourage Health Corp. First Quarter 2023 Results Conference Call. (Operator Instructions) The conference is being recorded. (Operator Instructions) A replay of this call will be available on the Entourage Health website later today and will remain posted for the next 90 days.

I would now like to turn the conference over to Catherine Flaman, Director of Communications with Entourage Health. Please go ahead, Catherine.

Catherine Flaman

Entourage Health Corp. - Senior Director of Communications & Corporate Affairs

Thank you, Brenda, and good morning, everyone. Welcome to Entourage Health's First Quarter 2023 Results Conference Call. Please note this call is being recorded. For copies of our press release and supporting documents or to receive recording of this call, please visit the Investor Relations page of our website at entouragehealthcorp.com. A replay will be available later this afternoon.

With us on today's call is George Scorsis, Chief Executive Officer and Executive Chairman of Entourage

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.